Global and China Neuropathic Pain Therapeutics Market Size, Status and Forecast 2023-2027

Report ID: 1015215 | Published Date: Jan 2025 | No. of Page: 105 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Neuropathic Pain Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Anticonvulsants
        1.2.3 Antidepressants
        1.2.4 NSAIDs
        1.2.5 Opioids
        1.2.6 Steroids
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Neuropathic Pain Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Diabetic Neuropathy
        1.3.3 Chemotherapy-Induced Neuropathy Pain
        1.3.4 Postherpetic Neuralgia
        1.3.5 Spinal Cord Injury
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Neuropathic Pain Therapeutics Market Perspective (2016-2027)
    2.2 Neuropathic Pain Therapeutics Growth Trends by Regions
        2.2.1 Neuropathic Pain Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Neuropathic Pain Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Neuropathic Pain Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Neuropathic Pain Therapeutics Industry Dynamic
        2.3.1 Neuropathic Pain Therapeutics Market Trends
        2.3.2 Neuropathic Pain Therapeutics Market Drivers
        2.3.3 Neuropathic Pain Therapeutics Market Challenges
        2.3.4 Neuropathic Pain Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Neuropathic Pain Therapeutics Players by Revenue
        3.1.1 Global Top Neuropathic Pain Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Neuropathic Pain Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Neuropathic Pain Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Neuropathic Pain Therapeutics Revenue
    3.4 Global Neuropathic Pain Therapeutics Market Concentration Ratio
        3.4.1 Global Neuropathic Pain Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Neuropathic Pain Therapeutics Revenue in 2020
    3.5 Neuropathic Pain Therapeutics Key Players Head office and Area Served
    3.6 Key Players Neuropathic Pain Therapeutics Product Solution and Service
    3.7 Date of Enter into Neuropathic Pain Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Neuropathic Pain Therapeutics Breakdown Data by Type
    4.1 Global Neuropathic Pain Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Neuropathic Pain Therapeutics Forecasted Market Size by Type (2022-2027)

5 Neuropathic Pain Therapeutics Breakdown Data by Application
    5.1 Global Neuropathic Pain Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Neuropathic Pain Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Neuropathic Pain Therapeutics Market Size (2016-2027)
    6.2 North America Neuropathic Pain Therapeutics Market Size by Type
        6.2.1 North America Neuropathic Pain Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Neuropathic Pain Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Neuropathic Pain Therapeutics Market Size by Type (2016-2027)
    6.3 North America Neuropathic Pain Therapeutics Market Size by Application
        6.3.1 North America Neuropathic Pain Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Neuropathic Pain Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Neuropathic Pain Therapeutics Market Size by Application (2016-2027)
    6.4 North America Neuropathic Pain Therapeutics Market Size by Country
        6.4.1 North America Neuropathic Pain Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Neuropathic Pain Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Neuropathic Pain Therapeutics Market Size (2016-2027)
    7.2 Europe Neuropathic Pain Therapeutics Market Size by Type
        7.2.1 Europe Neuropathic Pain Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Neuropathic Pain Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Neuropathic Pain Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Neuropathic Pain Therapeutics Market Size by Application
        7.3.1 Europe Neuropathic Pain Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Neuropathic Pain Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Neuropathic Pain Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Neuropathic Pain Therapeutics Market Size by Country
        7.4.1 Europe Neuropathic Pain Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Neuropathic Pain Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Neuropathic Pain Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Neuropathic Pain Therapeutics Market Size (2016-2027)
    9.2 Latin America Neuropathic Pain Therapeutics Market Size by Type
        9.2.1 Latin America Neuropathic Pain Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Neuropathic Pain Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Neuropathic Pain Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Neuropathic Pain Therapeutics Market Size by Application
        9.3.1 Latin America Neuropathic Pain Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Neuropathic Pain Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Neuropathic Pain Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Neuropathic Pain Therapeutics Market Size by Country
        9.4.1 Latin America Neuropathic Pain Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Neuropathic Pain Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Neuropathic Pain Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Neuropathic Pain Therapeutics Introduction
        11.1.4 Pfizer Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
        11.1.5 Pfizer Recent Development
    11.2 Novartis AG
        11.2.1 Novartis AG Company Details
        11.2.2 Novartis AG Business Overview
        11.2.3 Novartis AG Neuropathic Pain Therapeutics Introduction
        11.2.4 Novartis AG Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
        11.2.5 Novartis AG Recent Development
    11.3 AstraZeneca
        11.3.1 AstraZeneca Company Details
        11.3.2 AstraZeneca Business Overview
        11.3.3 AstraZeneca Neuropathic Pain Therapeutics Introduction
        11.3.4 AstraZeneca Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
        11.3.5 AstraZeneca Recent Development
    11.4 GlaxoSmithKline
        11.4.1 GlaxoSmithKline Company Details
        11.4.2 GlaxoSmithKline Business Overview
        11.4.3 GlaxoSmithKline Neuropathic Pain Therapeutics Introduction
        11.4.4 GlaxoSmithKline Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
        11.4.5 GlaxoSmithKline Recent Development
    11.5 Eli Lilly and Company
        11.5.1 Eli Lilly and Company Company Details
        11.5.2 Eli Lilly and Company Business Overview
        11.5.3 Eli Lilly and Company Neuropathic Pain Therapeutics Introduction
        11.5.4 Eli Lilly and Company Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
        11.5.5 Eli Lilly and Company Recent Development
    11.6 Mallinckrodt Pharmaceuticals
        11.6.1 Mallinckrodt Pharmaceuticals Company Details
        11.6.2 Mallinckrodt Pharmaceuticals Business Overview
        11.6.3 Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Introduction
        11.6.4 Mallinckrodt Pharmaceuticals Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
        11.6.5 Mallinckrodt Pharmaceuticals Recent Development
    11.7 Johnson & Johnson
        11.7.1 Johnson & Johnson Company Details
        11.7.2 Johnson & Johnson Business Overview
        11.7.3 Johnson & Johnson Neuropathic Pain Therapeutics Introduction
        11.7.4 Johnson & Johnson Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
        11.7.5 Johnson & Johnson Recent Development
    11.8 Abbott
        11.8.1 Abbott Company Details
        11.8.2 Abbott Business Overview
        11.8.3 Abbott Neuropathic Pain Therapeutics Introduction
        11.8.4 Abbott Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
        11.8.5 Abbott Recent Development
    11.9 Endo Pharmaceuticals, Inc.
        11.9.1 Endo Pharmaceuticals, Inc. Company Details
        11.9.2 Endo Pharmaceuticals, Inc. Business Overview
        11.9.3 Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Introduction
        11.9.4 Endo Pharmaceuticals, Inc. Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
        11.9.5 Endo Pharmaceuticals, Inc. Recent Development
    11.10 Teva Pharmaceutical Industries Limited
        11.10.1 Teva Pharmaceutical Industries Limited Company Details
        11.10.2 Teva Pharmaceutical Industries Limited Business Overview
        11.10.3 Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Introduction
        11.10.4 Teva Pharmaceutical Industries Limited Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
        11.10.5 Teva Pharmaceutical Industries Limited Recent Development
    11.11 Merck & Co
        11.11.1 Merck & Co Company Details
        11.11.2 Merck & Co Business Overview
        11.11.3 Merck & Co Neuropathic Pain Therapeutics Introduction
        11.11.4 Merck & Co Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
        11.11.5 Merck & Co Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Neuropathic Pain Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Anticonvulsants
    Table 3. Key Players of Antidepressants
    Table 4. Key Players of NSAIDs
    Table 5. Key Players of Opioids
    Table 6. Key Players of Steroids
    Table 7. Key Players of Others
    Table 8. Global Neuropathic Pain Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Neuropathic Pain Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Neuropathic Pain Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 11. Global Neuropathic Pain Therapeutics Market Share by Regions (2016-2021)
    Table 12. Global Neuropathic Pain Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 13. Global Neuropathic Pain Therapeutics Market Share by Regions (2022-2027)
    Table 14. Neuropathic Pain Therapeutics Market Trends
    Table 15. Neuropathic Pain Therapeutics Market Drivers
    Table 16. Neuropathic Pain Therapeutics Market Challenges
    Table 17. Neuropathic Pain Therapeutics Market Restraints
    Table 18. Global Neuropathic Pain Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 19. Global Neuropathic Pain Therapeutics Market Share by Players (2016-2021)
    Table 20. Global Top Neuropathic Pain Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropathic Pain Therapeutics as of 2020)
    Table 21. Ranking of Global Top Neuropathic Pain Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 22. Global 5 Largest Players Market Share by Neuropathic Pain Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Neuropathic Pain Therapeutics Product Solution and Service
    Table 25. Date of Enter into Neuropathic Pain Therapeutics Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Neuropathic Pain Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 28. Global Neuropathic Pain Therapeutics Revenue Market Share by Type (2016-2021)
    Table 29. Global Neuropathic Pain Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 30. Global Neuropathic Pain Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 31. Global Neuropathic Pain Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 32. Global Neuropathic Pain Therapeutics Revenue Market Share by Application (2016-2021)
    Table 33. Global Neuropathic Pain Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 34. Global Neuropathic Pain Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 35. North America Neuropathic Pain Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 36. North America Neuropathic Pain Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 37. North America Neuropathic Pain Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 38. North America Neuropathic Pain Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 39. North America Neuropathic Pain Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 40. North America Neuropathic Pain Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 41. Europe Neuropathic Pain Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 42. Europe Neuropathic Pain Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 43. Europe Neuropathic Pain Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 44. Europe Neuropathic Pain Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 45. Europe Neuropathic Pain Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 46. Europe Neuropathic Pain Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 47. Asia-Pacific Neuropathic Pain Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Neuropathic Pain Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Neuropathic Pain Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Neuropathic Pain Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Neuropathic Pain Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 52. Asia-Pacific Neuropathic Pain Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 53. Latin America Neuropathic Pain Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 54. Latin America Neuropathic Pain Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 55. Latin America Neuropathic Pain Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 56. Latin America Neuropathic Pain Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 57. Latin America Neuropathic Pain Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 58. Latin America Neuropathic Pain Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 59. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 64. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 65. Pfizer Company Details
    Table 66. Pfizer Business Overview
    Table 67. Pfizer Neuropathic Pain Therapeutics Product
    Table 68. Pfizer Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
    Table 69. Pfizer Recent Development
    Table 70. Novartis AG Company Details
    Table 71. Novartis AG Business Overview
    Table 72. Novartis AG Neuropathic Pain Therapeutics Product
    Table 73. Novartis AG Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
    Table 74. Novartis AG Recent Development
    Table 75. AstraZeneca Company Details
    Table 76. AstraZeneca Business Overview
    Table 77. AstraZeneca Neuropathic Pain Therapeutics Product
    Table 78. AstraZeneca Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
    Table 79. AstraZeneca Recent Development
    Table 80. GlaxoSmithKline Company Details
    Table 81. GlaxoSmithKline Business Overview
    Table 82. GlaxoSmithKline Neuropathic Pain Therapeutics Product
    Table 83. GlaxoSmithKline Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
    Table 84. GlaxoSmithKline Recent Development
    Table 85. Eli Lilly and Company Company Details
    Table 86. Eli Lilly and Company Business Overview
    Table 87. Eli Lilly and Company Neuropathic Pain Therapeutics Product
    Table 88. Eli Lilly and Company Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
    Table 89. Eli Lilly and Company Recent Development
    Table 90. Mallinckrodt Pharmaceuticals Company Details
    Table 91. Mallinckrodt Pharmaceuticals Business Overview
    Table 92. Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Product
    Table 93. Mallinckrodt Pharmaceuticals Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
    Table 94. Mallinckrodt Pharmaceuticals Recent Development
    Table 95. Johnson & Johnson Company Details
    Table 96. Johnson & Johnson Business Overview
    Table 97. Johnson & Johnson Neuropathic Pain Therapeutics Product
    Table 98. Johnson & Johnson Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
    Table 99. Johnson & Johnson Recent Development
    Table 100. Abbott Company Details
    Table 101. Abbott Business Overview
    Table 102. Abbott Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
    Table 103. Abbott Recent Development
    Table 104. Endo Pharmaceuticals, Inc. Company Details
    Table 105. Endo Pharmaceuticals, Inc. Business Overview
    Table 106. Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Product
    Table 107. Endo Pharmaceuticals, Inc. Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
    Table 108. Endo Pharmaceuticals, Inc. Recent Development
    Table 109. Teva Pharmaceutical Industries Limited Company Details
    Table 110. Teva Pharmaceutical Industries Limited Business Overview
    Table 111. Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Product
    Table 112. Teva Pharmaceutical Industries Limited Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
    Table 113. Teva Pharmaceutical Industries Limited Recent Development
    Table 114. Merck & Co Company Details
    Table 115. Merck & Co Business Overview
    Table 116. Merck & Co Neuropathic Pain Therapeutics Product
    Table 117. Merck & Co Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
    Table 118. Merck & Co Recent Development
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neuropathic Pain Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Anticonvulsants Features
    Figure 3. Antidepressants Features
    Figure 4. NSAIDs Features
    Figure 5. Opioids Features
    Figure 6. Steroids Features
    Figure 7. Others Features
    Figure 8. Global Neuropathic Pain Therapeutics Market Share by Application: 2020 VS 2027
    Figure 9. Diabetic Neuropathy Case Studies
    Figure 10. Chemotherapy-Induced Neuropathy Pain Case Studies
    Figure 11. Postherpetic Neuralgia Case Studies
    Figure 12. Spinal Cord Injury Case Studies
    Figure 13. Others Case Studies
    Figure 14. Neuropathic Pain Therapeutics Report Years Considered
    Figure 15. Global Neuropathic Pain Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 16. Global Neuropathic Pain Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 17. Global Neuropathic Pain Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 18. Global Neuropathic Pain Therapeutics Market Share by Regions (2022-2027)
    Figure 19. Global Neuropathic Pain Therapeutics Market Share by Players in 2020
    Figure 20. Global Top Neuropathic Pain Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropathic Pain Therapeutics as of 2020
    Figure 21. The Top 10 and 5 Players Market Share by Neuropathic Pain Therapeutics Revenue in 2020
    Figure 22. Global Neuropathic Pain Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 23. Global Neuropathic Pain Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 24. North America Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. North America Neuropathic Pain Therapeutics Market Share by Type (2016-2027)
    Figure 26. North America Neuropathic Pain Therapeutics Market Share by Application (2016-2027)
    Figure 27. North America Neuropathic Pain Therapeutics Market Share by Country (2016-2027)
    Figure 28. United States Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Canada Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe Neuropathic Pain Therapeutics Market Share by Type (2016-2027)
    Figure 32. Europe Neuropathic Pain Therapeutics Market Share by Application (2016-2027)
    Figure 33. Europe Neuropathic Pain Therapeutics Market Share by Country (2016-2027)
    Figure 34. Germany Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. France Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. U.K. Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Italy Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Russia Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Nordic Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific Neuropathic Pain Therapeutics Market Share by Type (2016-2027)
    Figure 42. Asia-Pacific Neuropathic Pain Therapeutics Market Share by Application (2016-2027)
    Figure 43. Asia-Pacific Neuropathic Pain Therapeutics Market Share by Region (2016-2027)
    Figure 44. China Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Japan Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. South Korea Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Southeast Asia Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. India Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Australia Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America Neuropathic Pain Therapeutics Market Share by Type (2016-2027)
    Figure 52. Latin America Neuropathic Pain Therapeutics Market Share by Application (2016-2027)
    Figure 53. Latin America Neuropathic Pain Therapeutics Market Share by Country (2016-2027)
    Figure 54. Mexico Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Brazil Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa Neuropathic Pain Therapeutics Market Share by Type (2016-2027)
    Figure 58. Middle East & Africa Neuropathic Pain Therapeutics Market Share by Application (2016-2027)
    Figure 59. Middle East & Africa Neuropathic Pain Therapeutics Market Share by Country (2016-2027)
    Figure 60. Turkey Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Saudi Arabia Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. UAE Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. Pfizer Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
    Figure 64. Novartis AG Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
    Figure 65. AstraZeneca Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
    Figure 66. GlaxoSmithKline Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
    Figure 67. Eli Lilly and Company Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
    Figure 68. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
    Figure 69. Johnson & Johnson Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
    Figure 70. Abbott Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
    Figure 71. Endo Pharmaceuticals, Inc. Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
    Figure 72. Teva Pharmaceutical Industries Limited Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
    Figure 73. Merck & Co Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Novartis AG
AstraZeneca
GlaxoSmithKline
Eli Lilly and Company
Mallinckrodt Pharmaceuticals
Johnson & Johnson
Abbott
Endo Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Limited
Merck & Co
Frequently Asked Questions
Neuropathic Pain Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neuropathic Pain Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neuropathic Pain Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports